ArticleTherapeutic advances in gastroenterology2021

α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis.

Michaela Melde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.